Inflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER.
| Excerpt | Reference |
|---|
| "If colitis is present, it should be managed aggressively, probably with corticosteroids and with intensive supportive measures." | ( Ramirez-Ronda, CH; Sandford, JP, 1975) |
| "If colitis is found, the antibiotic should be discontinued, vigorous supportive therapy should be instituted, and the patient should be observed carefully." | ( Tedesco, FJ, 1975) |
| "Collagenous colitis is a rare condition characterized clinically by chronic diarrhea and histologically by a thickened subepithelial collagenous band in colonic biopsies in an endoscopically normal colon." | ( Blok, P; Dekker, W; Lam, HG; Meuwissen, SG; Seldenrijk, CA; Stel, HV; van Tilburg, AJ, 1990) |
| "Microscopic colitis is responsible for a proportion of cases of intractable diarrhoea of obscure origin and rectal and colonic biopsies sould be undertaken in such cases." | ( Ball, JA; Dawson, AM; Kingham, JG; Levison, DA, 1982) |
| "Collagenous colitis is a very rarely recognized disease characterized clinically by watery diarrhoea and histologically by a broad, band-like deposition of collagen under the surface epithelium of the colon and rectum." | ( Gudmand-Høyer, E; Mogensen, AM; Olsen, JH, 1984) |
| "Hemorrhagic colitis is a rare but well-recognized complication with ampicillin or penicillin derivative treatment." | ( Chadwick, VS; Keshavarzian, A; Saverymuttu, SH, 1984) |
| "Microscopic colitis is a recently recognized cause of diarrhoea, predominantly affecting older women, but its response to treatment is poorly documented." | ( Fasoli, R; Jewell, DP, 1994) |
| "Cytomegalovirus colitis is one of the sequelae of cytomegalovirus infection in transplant patients and can be associated with severe consequences." | ( Bolman, RM; Braunlin, EA; Etheridge, SP, 1994) |
| "Hapten-induced colitis is a widely used model for the study of the intestinal inflammation and for the testing of novel therapies." | ( Appleyard, CB; Beck, PL; Carter, L; Le, T; Wallace, JL, 1995) |
| "Collagenous colitis is characterized by chronic watery diarrhea and a greater than 10 micron-thick collagen deposit in the subepithelial layer of the colonic mucosa." | ( Baron, D; Le Goff, P; Robert, FX; Saraux, A; Soulier, C, 1996) |
| "Collagenous colitis is a chronic diarrheal disease characterized by a normal or near-normal mucosa endoscopically and microscopic inflammation in the lamina propria, surface epithelial injury and a thick subepithelial collagen layer." | ( Appelman, HD; Barnett, JL; Goff, JS; Pelke, T, 1997) |
| "Diversion colitis is thought to result from nutritional deficiencies secondary to fecal diversion." | ( Chuang, TY; Francisco, GE; Lai, JM; Strayer, JR, 1997) |
| "Distal colitis is associated with regional differences in colonic circular smooth muscle contractility, which may contribute to delayed transit in the proximal colon and rapid transit in the distal colon." | ( Dempsey, DT; Martin, JS; Myers, BS; Parkman, HP; Ryan, JP; Yasar, S, 1997) |
| "Experimental colitis is associated with hepatobiliary complications and an increased hepatocyte tight junctional permeability to horseradish peroxidase and lanthanum." | ( Citi, S; d'Odorico, A; Fries, W; Lora, L; Martin, A; Martines, D; Mazzon, E; Muraca, M; Naccarato, R, 1997) |
| "Lymphocytic colitis is a rare inflammatory colonic disease of unknown etiology accompanied by watery diarrhea." | ( Peny, MO; Schmit, A; Van Gossum, A, 1998) |
| "Most ischemic colitis is idiopathic, but some may be caused by E." | ( Alt, E; Brandt, LJ; Patterson, K; Sigal, SH; Steinberg, JJ; Su, C; Tarr, PI, 1998) |
| "Gold colitis are reported 36 cases in rheumatoid arthritis patients." | ( Sakurai, Y, 1998) |
| "Oxazolone colitis is a T helper cell type 2 (Th2)-mediated process since stimulated T cells from lesional tissue produce markedly increased amounts of interleukin (IL)-4 and IL-5; in addition, anti-IL-4 administration leads to a striking amelioration of disease, whereas anti-IL-12 administration either has no effect or exacerbates disease." | ( Boirivant, M; Chu, A; Fuss, IJ; Strober, W, 1998) |
| "Collagenous colitis is an uncommon cause of chronic diarrhea and the association of collagenous colitis with Addison's disease has not previously been described." | ( Bayram, F; Keleştimur, F; Kirgin, A; Ozbakir, O; Patiroglu, T; Unlühizarci, K; Yücesoy, M, 1998) |
| "Distal colitis is associated with abnormal myoelectrical activity in the noninflamed ileum of rats." | ( Aube, AC; Barbier, M; Cherbut, C; Galmiche, JP; Roze, C; Xing, JH, 1999) |
| "Collagenous colitis is a rare cause of chronic watery diarrhea." | ( Dienes, HP; Dries, V; Kruis, W; Lanyi, B, 1999) |
| "Lymphocytic colitis is a chronic diarrhea syndrome with no endoscopically detectable anomaly and histological colonic lesions." | ( Bronstein, JA; Farret, O; Gros, P; Mennecier, D; Thiolet, C, 1999) |
| "Lymphocytic colitis is uncommon." | ( Bronstein, JA; Farret, O; Gros, P; Mennecier, D; Thiolet, C, 1999) |
| "Collagenous colitis is a chronic watery diarrhea disorder characterized by a subepithelial collagen layer and a lymphoplasmacytic infiltration within the lamina propria." | ( Fisseler-Eckhoff, A; Griga, T; May, B; Möllmann, HW; Müller, KM; Tromm, A, 1999) |
| "Lymphocytic colitis is a clinico-pathological syndrome characterized by chronic diarrhea, normal endoscopy, diffuse colonic mucosal inflammatory changes." | ( Abd Alsamad, I; Chousterman, M; Cohen, C; Fléjou, JF; Hagege, H; Nahon, S; Rosa, I, 1999) |
| "Microscopic colitis is a syndrome consisting of chronic watery diarrhea, a normal or near-normal gross appearance of the colonic lining, and a specific histological picture described as either lymphocytic colitis or collagenous colitis." | ( Schiller, LR, 1999) |
| "Lymphocytic colitis is a chronic inflammatory colonic disease characterized by watery diarrhea and a dense infiltration of the colonic mucosa with lymphocytes." | ( Bartz, KO; Feurle, GE; Schmitt-Gräff, A, 1999) |
| "Although CMV colitis is most frequently observed in immunosuppressed patients such as those with acquired immune deficiency syndrome (AIDS), transplants and corticosteroid treatment, it has also been reported in less immunosuppressed (elderly, malnourished,." | ( Colpaert, C; Schrijvers, D; Van den Brande, J; Vermorken, JB, 1999) |
| "Chronic toxic colitis is accompanied by a considerable redistribution of plasmocytes-producers of the main immunoglobulins classes in the colon walls towards a primary IgA producers increase, a correlation between them and the local immune reactions tension and destabilization as well." | ( Hnatiuk, MS; Soroka, NIe, 1999) |
| "Experimental colitis is associated with anorexia that is attenuated by treatment with an interleukin (IL)-1 receptor antagonist." | ( Ballinger, A; Dryden, S; El-Haj, T; Farthing, MJ; Obeid, O; Perrett, D; Turvill, J; Williams, G, 2000) |
| "Lymphocytic colitis is a rare clinicopathologic syndrome, characterized by chronic watery diarrhea, diffuse inflammatory changes in the colonic mucous in spite of normal findings on colonoscopy and marked intraepithelial lymphocytic infiltration on biopsy." | ( Arenas Gracia, M; Calduch Broseta, JV; Martínez López, V; Mata Medina, B; Segarra Soria, MM; Serrano Corredor, MS, 2000) |
| "Colitis is accompanied by a significant accumulation in MLN of T lymphocytes positive for several cell surface adhesion molecules characteristic for memory T cells." | ( Bryniarski, K; Gryglewski, A; Ptak, W; Stachura, J; Szczepanik, M, 2000) |
| "Collagenous colitis is a disease characterized by chronic watery diarrhea, and on microscopic examination of colonic tissue, a typical thickening of the subepithelial collagen layer is seen." | ( Benoni, C; Bruce, K; Egesten, A; Maim, J; Ståhle-Bäckdahl, M; Veress, B, 2000) |
| "Colitis is associated with a profound stimulation of adrenocortical cell function and glucocorticoid release." | ( Bornstein, SR; Bouma, G; Chrousos, GP; Franchimont, D; Galon, J; Haidan, A; Wolkersdörfer, GW, 2000) |
| "Collagenous colitis is a disorder which has been diagnosed with increasing frequency in the last few years, probably due to the routine obtention of colon biopsy specimens in the study of patients with chronic diarrhoea." | ( del Pozo, D; García Hoz, F; Gil Grande, LA; Miquel Plaza, J; Peña, E, 2000) |
| "Collagenous colitis is a treatable condition in most patients." | ( Fiedler, LM; George, J; Harpaz, N; Janowitz, HD; Kornbluth, AA; Sachar, DB, 2001) |
| "Development of colitis is dependent on accumulation of activated CD134L+ dendritic cells (DC) in the mesenteric lymph nodes, which is inhibited by CD4+CD25+ cells, indicating that regulatory T cells may control DC activation in vivo." | ( Asseman, C; Malmström, V; Mottet, C; Powrie, F; Read, S; Singh, B; Stepankova, R; Stephens, LA; Tlaskalova, H, 2001) |
| "Collagenous colitis is a diarrheal illness of unknown cause." | ( Mattia, A; Wilcox, GM, 2002) |
| "Eosinophilic colitis is a relatively rare complication of hypereosinophilic syndrome which is characterized by abdominal pain and bloody diarrhea and is usually treated with steroids and hydroxyurea." | ( Cho, HG; Jang, CS; Jeong, S; Kim, HG; Kim, PS; Kim, YS; Kwon, ES; Kwon, KS; Lee, DH; Lee, JH; Lee, JW; Min, HY; Shin, YW, 2002) |
| "Microscopic colitis is an umbrella term used to include two idiopathic inflammatory bowel disorders that present with chronic watery diarrhea, normal endoscopic findings and characteristic inflammatory changes on histology." | ( Bhathal, P; Gibson, P; Tagkalidis, P, 2002) |
| "Ulcerative colitis is a chronic disorder of unknown etiology." | ( Anagnostakis, E; Andreadou, I; Demonakou, M; Govosdis, V; Kourounakis, PN; Papalois, A; Triantafillidis, JK; Vidali, M, 2002) |
| "In humans, colitis is associated with increased expression of pro-inflammatory cytokines." | ( Cripps, PJ; Davidson, AJ; Edwards, GB; Matthews, JB; Proudman, CJ, 2002) |
| "Colitis is amplified by deficiency and ameliorated by supplementation of the vitamin." | ( Ghebermeskel, K; Nur, T; Pines, M; Reifen, R; Urizky, R; Zaiger, G, 2002) |
| "Collagenous colitis is an idiopathic microscopic colitis characterized by chronic watery diarrhea, a typical subepithelial collagen layer, and lymphoplasmacellular infiltration." | ( Bartram, HP; Bästlein, E; Bayerdörffer, E; Bethke, B; DeLarive, J; Dorta, G; Heymer, P; Lehn, N; Meier, E; Miehlke, S; Stolte, M; Tromm, A; Wilhelms, G, 2002) |
| "Collagenous colitis is a disorder that is recognized as a cause of chronic diarrhea." | ( Chande, N; MacDonald, JK; McDonald, JW, 2002) |
| "Collagenous colitis is characterised by diarrhoea, lymphocytic inflammation, and a thickened subepithelial collagen layer in the colorectal mucosa." | ( Birket-Smith, L; Bonderup, OK; Fallingborg, J; Hansen, JB; Teglbjaerg, PS; Vestergaard, V, 2003) |
| "Collagenous colitis is a disorder that is recognized as a cause of chronic diarrhea." | ( Chande, N; MacDonald, JK; McDonald, JW, 2003) |
| "Because rabbit colitis is characterized by a loss of inhibitory neurotransmission we hypothesized it might affect the rebound response." | ( Depoortere, I; Peeters, TL; Thielemans, L; Thijs, T, 2003) |
| "Microscopic colitis is a disease of unknown aetiology characterized by chronic watery diarrhoea and diarrhoea can be eliminated by budesonide but frequently recurs when budesonide is stopped." | ( Fischer Hansen, B; Kjeldsen, J; Munck, LK; Philipsen, E, 2003) |
| "Collagenous colitis is a disorder that is recognized as a cause of chronic diarrhea." | ( Chande, N; MacDonald, JK; McDonald, JW, 2003) |
| "Collagenous colitis is a disorder that is recognized as a cause of chronic diarrhea." | ( Nielsen, OH; Schaffalitzky de Muckadell, OB, 2003) |
| "Collagenous colitis is one of the microscopic colitides, which are thought to be on the same spectrum of disease as Crohn's disease and ulcerative colitis." | ( Batra, AK; Levey, JM; Patwardhan, R; Trister, J, 2003) |
| "MMF-related colitis is a distinct entity that displays histologic features remarkably similar to the ones associated with intestinal GVHD." | ( Cangro, CB; Drachenberg, CB; Khaled, A; Klassen, DK; Lustberg, A; Nogueira, J; Papadimitriou, JC; Ramos, E; Wiland, A, 2003) |
| "Collagenous colitis is a disorder that is recognized as a cause of chronic diarrhea." | ( Chande, N; MacDonald, JK; McDonald, JW, 2004) |
| "Collagenous colitis is a chronic inflammatory bowel disease with a band-like subepithelial deposition of immature extracellular matrix." | ( Brasch, F; Griga, T; Müller, KM; Pfisterer, O; Schmiegel, W; Tromm, A, 2004) |
| "Microscopic colitis is an idiopathic chronic inflammatory bowel disease presenting with watery diarrhea." | ( Delgado, B; Delgado, J; Fich, A; Odes, S, 2004) |
| "Colitis is a rare but serious gastrointestinal complication associated with taxane-based chemotherapy in patients with cancer." | ( Buzdar, AU; Hortobagyi, GN; Ibrahim, NK; Li, Z; Mante Menchu, RP; Theriault, R; Valero, V; Wang, M; Wathen, JK, 2004) |
| "Stercoral colitis is an inflammatory process involving the colonic wall related to fecal impaction." | ( Heffernan, C; Macari, M; Megibow, AJ; Pachter, HL, 2005) |
| "The chronic colitis is related to increased CD4-positive infiltrating T cells displaying memory and naive phenotypes, and an altered vascular endothelium with aberrant expression of peripheral node addressin." | ( Butcher, EC; Habtezion, A; Omary, MB; Toivola, DM, 2005) |
| "Ulcerative colitis is a chronic recurrent inflammatory bowel disease in which oxidative stress has been implicated." | ( Bulbuloglu, E; Buyukbese, MA; Cetinkaya, A; Ciralik, H; Kantarceken, B; Kurutas, EB, 2005) |
| "Chemical colitis is associated with a significant decrease in jejunal net fluid absorption." | ( Barada, KA; Bou Rached, NA; Khoury, CI; Mourad, FH; Nassar, CF; Saadé, NE, 2006) |
| "Collagenous colitis is a disorder that is recognized as a cause of chronic diarrhea." | ( Chande, N; Macdonald, JK; McDonald, JW, 2005) |
| "Haemorrhagic colitis is a known side effect of amoxicillin that is rarely seen." | ( Hack, WW; Labadie, J; van Hensbroek, PB, 2005) |
| "Acute colitis is characterized by an extensive disturbance of microcirculation together with signs of systemic inflammatory response syndrome." | ( Anderson, T; Buhr, HJ; Kruschewski, M; Loddenkemper, C, 2006) |
| "Ulcerative colitis is a multifactorial disease, with immunological, genetic, and environmental factors playing an important role in its pathogenesis." | ( Falk, W; Neumann, ID; Obermeier, F; Reber, SO; Straub, HR; Straub, RH, 2006) |
| "Ulcerative colitis is a multifactorial inflammatory disease of the colon and rectum with an unknown etiology." | ( Barbaros, U; Giriş, M; Güloğlu, R; Gündüz, M; Necefli, A; Olgaç, V; Toker, G; Tulumoğlu, B, 2006) |
| "Ulcerative colitis is a multifactorial inflammatory disease of the colon and rectum with an unknown etiology." | ( Abbasoğlu, SD; Değer, C; Erbil, Y; Giriş, M; Olgaç, V; Oztezcan, S; Toker, G; Tunca, F; Yanik, BT, 2006) |
| "Ulcerative colitis is characterized by elevated rates of epithelial cell apoptosis, and an up-regulation of pro-apoptotic cytokines including tumor necrosis factor alpha (TNF-alpha)." | ( Greenson, JK; Haxhija, EQ; Spencer, AU; Teitelbaum, DH; Wildhaber, BE; Yang, H, 2007) |
| "TNBS colitis is associated with visceral and somatic hypersensitivity in areas of somatotopic overlap." | ( Caudle, RM; Price, DD; Verne, GN; Zhou, Q, 2008) |
| "Ulcerative colitis is an inflammatory bowel disease of uncertain etiology with recurrent symptoms and considerable morbidity." | ( Dalal, L, 2007) |
| "Ulcerative colitis is an autoimmune-inflammatory disease characterized by increased proliferation of colonic epithelial cells, dysregulation of signal transduction pathways, elevated mucosal T cell activation, increased production of proinflammatory cytokines, and enhanced leukocyte infiltration into colonic interstitium." | ( Bhatia, DR; Bhatt, P; Bhonde, MR; Dadarkar, SD; Dagia, NM; Deore, V; Desai, NK; Gupte, RD; Jadhav, MG; Kumar, S; Sharma, S; Tannu, AA; Vishwakarma, RA; Yewalkar, N, 2008) |
| "We examined whether colitis is associated with altered electrogenic ion transport in the ileal mucosa and/or changes in the properties of ileal submucosal neurons." | ( Burda, JE; Grider, JR; Hons, IM; Mawe, GM; Sharkey, KA, 2009) |
| "Phlegmonous colitis is an acute suppurative infection of the large bowel that is rarely described, rapidly fatal and often escapes clinical attention." | ( de Silva, K; Jones, BE; Napoli, J; Pang, SH, 2009) |
| "Although CMV colitis is common in immunocompromised patients, we believe this is the first case of CMV colitis with megacolon and recurrent CMV infection in an immunocompetent patient." | ( Chang, MC; Chen, YJ; Cheng, HT; Lin, YH; Su, IH; Yeh, CJ, 2010) |
| "Ulcerative colitis is an idiopathic, chronic inflammatory disease of the colon associated with a high colon cancer risk." | ( Chumanevich, A; Cui, X; Habiger, J; Hofseth, AB; Hofseth, LJ; Jin, Y; Nagarkatti, M; Nagarkatti, PS; Pena, E; Poudyal, D; Singh, UP, 2010) |
| "Colitis is difficult to detect and monitor noninvasively." | ( Bissonnette, M; Dougherty, U; Fan, X; Hart, J; Karczmar, GS; Markiewicz, E; Mustafi, D; Oto, A; Zamora, M, 2010) |
| "Colitis is associated with increased excitability of afterhyperpolarization neurons (AH neurons) and facilitated synaptic transmission in the myenteric plexus." | ( Hoffman, JM; Mawe, GM; McKnight, ND; Sharkey, KA, 2011) |
| "Eosinophilic colitis is an idiopathic inflammation of the alimentary canal and is characterized by infiltration of the intestinal wall by eosinophils, massive submucosal edema, and peripheral eosinophilia." | ( Katsanos, KH; Lambri, E; Tsianos, EV; Zinovieva, E, 2011) |
| "Animal models of colitis are widely used to study the pathogenesis of inflammatory bowel diseases (IBD) and irritable bowel syndrome (IBS)." | ( De Man, JG; De Winter, BY; Moreels, TG; Nullens, S; Pelckmans, PA; Vermeulen, W, 2011) |
| "Eosinophilic colitis is a rare adverse effect of clozapine." | ( Clahsen, PC; de Raad, AW; Hagestein-de Bruijn, C; Siegersma, NC, 2011) |
| "Ulcerative colitis is a gastrointestinal disorder characterized by local inflammation and impaired epithelial barrier." | ( Hu, KF; Li, SW; Wang, FY; Xia, XM; Zhou, J; Zou, BB, 2011) |
| "Colitis is the common pathological lesion of inflammatory bowel diseases." | ( Ho, TY; Hsiang, CY; Huang, HC; Li, CC; Lo, HY; Wu, SL, 2013) |
| "Colitis is the term used for chronic inflammatory bowel diseases at substantially increased risk of developing a form of colorectal cancer (CRC) known as colitis-associated cancer." | ( Benaglia, M; Caggiano, C; Campieri, M; Gionchetti, P; Lazzarini, G; Papi, A; Rizzello, F; Spisni, E; Strillacci, A; Valerii, MC, 2013) |
| "Acute colitis is a form of inflammatory bowel disease (IBD) with chronic inflammatory disorder of the bowel." | ( Chandrasekaran, VR; Hsu, DZ; Liu, MY; Periasamy, S, 2013) |
| "Microscopic colitis is characterized by chronic or intermittent watery diarrhoea." | ( Lukáš, K; Mandys, V, 2013) |
| "Ulcerative colitis is a chronic inflammatory disease and involves multiple etiological factors." | ( Chen, X; Ding, B; Hou, Y; Liu, Y; Long, M; Wang, L; Wang, Q; Wu, G; Yi, D, 2013) |
| "Eosinophilic colitis is a rare mostly self-limiting disease affecting middle-aged adults." | ( Alfadda, AA; Shaffer, EA; Storr, MA; Urbanski, SJ, 2014) |
| "Ulcerative colitis is a disease that causes inflammation and ulcer in the lining of the large intestine." | ( C, G; V, VP, 2014) |
| "Obstructive colitis is predominantly diffuse and contiguous with the obstructing adenocarcinoma." | ( Chung, YA; Han, EJ; Kim, SH; Lee, SH; Oh, JK; Park, HL; Park, SY; Park, YH, 2014) |
| "Ulcerative colitis is a chronically recurrent inflammatory bowel disease of unknown origin." | ( Ghannadi, AR; Mahzooni, P; Mehrzadi, S; Minaiyan, M; Rashidian, A; Sadr, S, 2014) |
| "Ulcerative colitis is inflammatory conditions of the colon caused by interplay of genetic and environmental factors." | ( Ching, YH; Chiu, CC; Chuang, HL; Huang, YT; Li, YP; Liu, JY; Wang, YC, 2014) |
| "Ulcerative colitis is a chronic inflammatory condition of the colon, and reactive oxidative metabolites (ROMs) play an important role in its pathogenesis." | ( Can, M; Dogan, Z; Ergul, B; Filik, L; Gonultas, MA; Hucumenoglu, S; Sarikaya, M, 2014) |
| "Ulcerative colitis is a chronic inflammatory disease that frequently progresses to colon cancer." | ( Hamada, T; Hayashi, S; Ishii, Y; Kadowaki, M; Lee, J; Oshiro, M; Sasahara, M; Yamamoto, T; Zaidi, SF, 2014) |
| "Colitis is associated with functional abnormalities in proximal non-inflamed gut areas, but animal models to study small bowel dysfunction in colitis have limitations." | ( Barada, K; Mourad, FH; Noutsi, B; Saadé, NE, 2015) |
| "Ulcerative colitis is a dynamic, idiopathic, chronic inflammatory condition that carries a high colon cancer risk." | ( Causey, CP; Cui, X; Hofseth, AB; Hofseth, LJ; Subramanian, V; Thompson, PR; Witalison, EE, 2015) |
| "CMV colitis is relatively common in immunocompromised patients; however, it is rare in immunocompetent patients." | ( Aomatsu, K; Aomatsu, N; Hasegawa, T; Nakamura, M, 2015) |
| "Ulcerative colitis is a chronic inflammatory disease of the colon." | ( Ağış, ER; Melli, M; Savaş, B, 2015) |
| "Acute colitis is induced in female Balb/c mice by administration of 5% dextran sodium sulfate (DSS) for 5 days." | ( Luo, L; Thorlacius, H; Wang, Y; Yu, C; Zhang, S, 2016) |
| "Eosinophilic colitis is a rare heterogeneous condition, the pathogenesis of which is likely to be an interplay between environmental and genetic factors." | ( Hume, S; Mogilevski, T; Nickless, D, 2015) |
| "OXA colitis is exacerbated in IL-33 and ST2 mice." | ( Coburn, LA; Denson, LA; Fei, L; Hogan, SP; Hummel, AT; Minar, P; Moore, PD; Nakae, S; Rosen, MJ; Shanmukhappa, SK; Vallance, JE; Waddell, A; Washington, MK; Wilson, KT; Wu, D, 2015) |
| "Colitis is an inflammation of the colon." | ( Chandekar, A; Jagdale, S, 2016) |
| "Drug induced colitis is a very rare side effect of trientine." | ( Boga, S; Jain, D; Schilsky, ML, 2015) |
| "Ulcerative colitis is an inflammatory condition of the colon in the gastrointestinal system." | ( Akşit, H; Ayvaz, S; Can, G; Can, H; Demirtaş, S; Karaboğa, İ; Karaca, T; Korkmaz, U; Kurt, M; Yılmaz, B, 2016) |
| "However, CMV colitis is increasingly recognized in immunocompetent hosts." | ( Chan, KS; Lee, WY; Yu, WL, 2016) |
| "Severity of colitis is evaluated by changing of body weight, bloody stool, fecal consistency, histology evaluation and cytokine expression." | ( Chen, M; Fan, R; Hu, S; Lin, Y; Liu, X; Pei, Y; Tao, R; Wang, L; Wang, Y; Wang, Z; Zhang, M; Zhang, T; Zheng, S; Zhong, J; Zhou, J, 2016) |
| "Colitis is a common complication after treatment with antibiotics such as β-lactams, quinolones, and aminoglycosides." | ( Alikhani, MY; Khodaparast, S; Moghadam, MK; Mousavi, SF; Mozaffari Nejad, AS; Shahcheraghi, F, 2016) |
| "Ulcerative colitis is a chronic recurrent disease with incomplete treatment options." | ( Ghasemi-Pirbaluti, M; Hosseini, MJ; Motaghi, E; Najafi, A, 2017) |
| "Ulcerative colitis is the typical progression of chronic inflammatory bowel disease." | ( Aoyama, Y; Aso, H; Hirahara, K; Islam, J; Komai, M; Sato, S; Shirakawa, H; Tomita, S; Watanabe, K; Watanabe, T, 2017) |
| "Ulcerative colitis is a multi-factorial disease involving a dysregulated immune response." | ( Chelakkot, C; Choi, JS; Ghim, J; Jang, MH; Kim, JH; Rajasekaran, N; Ryu, SH; Shin, YK; Suh, PG, 2017) |
| "Colitis is a well-known subtype of inflammatory bowel disease and is caused by diverse factors." | ( Kim, DG; Lee, MR; Ma, JY; Park, KI; Yoo, JM, 2017) |
| "Radiation-induced colitis is a common clinical problem associated with radiotherapy and accidental exposure to ionizing radiation." | ( Jang, H; Jang, WS; Jin, YW; Kim, H; Lee, C; Lee, J; Lee, SJ; Lee, SS; Myung, H; Myung, JK; Park, S; Shim, S, 2018) |
| "TNBS-induced colitis is an experimental immunopathology in rats that shares many features with human inflammatory bowel diseases." | ( Barbosa, MMC; Bracht, A; Bracht, L; Castro-Ghizoni, CV; Comar, JF; Lameira, OA; Natali, MRM; Peralta, RM; Sa-Nakanishi, AB; Vicentini, FA, 2018) |
| "Eosinophilic colitis is a rare clinical condition that belongs to the group of eosinophilic gastrointestinal disorders." | ( Barragry, J; Begent, J; Fernando, CS; Fragkos, KC; Novelli, M; Zárate-Lopez, N, 2018) |
| "Ulcerative colitis is an idiopathic inflammatory bowel disease characterized by intestinal inflammation; blocking this inflammatory process may be the key to the development of new naturally occurring anti-inflammatory drugs, with greater efficiency and lower side effects." | ( Alarcón de la Lastra, C; Castejon Martinez, ML; Lopes de Oliveira, GA; Rolim Medeiros, JV; Rosillo, MÁ; Sánchez-Hidalgo, M; Villegas, I, 2019) |
| "Ulcerative colitis is a common intestinal inflammatory disease characterized by upregulation of pro-inflammatory cytokines and oxidative stress." | ( El-Akabawy, G; El-Sherif, NM, 2019) |
| "Radiation induced colitis is one the most common clinical issue for patients receiving radiotherapy." | ( Acikgoz, B; Aydin, BG; Can, M; Elmas, O; Guven, B; Karakaya, K; Piskin, O, 2019) |
| "Diversion colitis is still very common in our country, since the stoma creation is a common practice especially in situations of trauma." | ( Bernardi, LU; Dourado, DM; Ferreira, VC; Leonel, POS; Lima, AM; Matias, R; Nascimento, CEC; Rigo, GM; Santos, CHMD; Siqueira, GEC; Souza, VCRP, 2019) |
| "CMV colitis is generally associated with an immunosuppressed state." | ( Dumot, J; Guler, E; Ramaiya, NH; Shieh, AC; Tirumani, SH, 2020) |
| "Colitis is an inflammatory bowel disease with chronic nature." | ( Ashrafizadeh, M; Farkhondeh, T; Mohammadinejad, R; Najafi, M; Samarghandian, S, 2020) |
| "The colitis is T cell-mediated and dependent on the microbiome." | ( Bissonnette, M; He, C; Huang, H; Lu, TX; Sun, HL; Zhang, L; Zheng, Z, 2020) |
| "Ulcerative colitis is an inflammatory condition of the colon." | ( Liu, X; Sun, Z; Wang, H, 2021) |
| "Colitis is a rare adverse event of Lenvatinib, and this is the first detailed report of colitis induced by Lenvatinib with endoscopic findings." | ( Doyama, H; Katayanagi, K; Kito, Y; Kubo, A; Matsunaga, K; Minato, H; Miyajima, S; Tsuji, K; Tsuji, S; Ushijima, K; Yonezawa, M; Yoshida, N, 2021) |
| "Ulcerative colitis is a chronic and recurrent inflammatory bowel disease mediated by immune response." | ( Li, C; Liu, Y; Pu, Z; Xie, H; Xu, M; Zhao, J, 2020) |
| "Hemorrhagic colitis is a unique gastrointestinal adverse events associated with dasatinib and its pathogenesis remains poorly understood." | ( Ikejiri, F; Inoue, M; Ishihara, S; Ishimura, N; Kawashima, K; Kinoshita, Y; Mishima, Y; Moriyama, I; Okada, T; Onishi, C; Oshima, N; Shibagaki, K; Suzumiya, J, 2021) |
| "Ulcerative colitis is a recrudescent intestinal inflammation coupled with diarrhea, weight loss, pus, and blood stool, which seriously impacts the quality of patient life." | ( Cai, J; Lin, Y; Su, J; Su, Z; Sun, Z; Wang, M; Wei, L; Wu, X; Wu, Y; Yi, X, 2021) |
| "Ulcerative colitis is a type of chronic inflammatory bowel disease closely associated with gut microbiota dysbiosis and intestinal homeostasis dysregulation." | ( Chen, F; Feng, Y; Hu, X; Ji, J; Li, D; Tian, M, 2021) |
| "Long-standing colitis is associated with increased risk of colon cancer." | ( Ashktorab, H; Banskota, S; Brim, H; Khan, WI; Kwon, YH; Singh, G; Sinha, SR; Wang, H, 2021) |
| "Ulcerative colitis is a subtype of inflammatory bowel disease, characterized by relapsing inflammation in the gastrointestinal tract with limited treatment options." | ( Chen, SG; Kwok, HF; Lau, CB; Lee, JK; Li, XX; Shaw, PC; Simmonds, MSJ; Yue, GG; Zheng, T, 2021) |
| "Colitis is a common disease of the colon that is very difficult to treat." | ( Chen, GQ; Li, ZH; Liu, X; Liu, XY; Wu, F; Yan, X; Zhang, D; Zhang, YD, 2021) |
| "Ulcerative colitis is a chronic inflammatory disease, profoundly affecting the patient's quality of life and is associated with various complications." | ( El-Bahy, AAZ; El-Ghannam, MS; El-Yamany, MF; Nassar, NN; Saad, MA, 2022) |
| "Colitis is a main presentation of inflammatory bowel disease (IBD) and yet, has no definitive cure." | ( Ala, M; Dehpour, AR; Jafari, RM; Nematian, H; Shadboorestan, A, 2022) |
| "Ulcerative colitis is a recurrent inflammatory illness of the colon with an elevated risk of developing colon cancer." | ( Bettadaiah, BK; Mathew, NS; Muthukumar, SP; Negi, PS, 2022) |
| "Ulcerative colitis is the most prevalent forms of inflammatory bowel diseases and a refractory autoimmune disease and affects millions of people worldwide." | ( Ouyang, J; Sun, L; Wu, S; Zeng, F, 2022) |
| "DSS-induced mice colitis is used to verify the protective effects of phillygenin on intestinal barrier and tight junction." | ( Feng, H; He, L; Liu, Z; Pi, B; Wang, Z, 2022) |
| "Ulcerative colitis is a complex inflammatory bowel disorder disease that can induce rectal and colonic dysfunction." | ( Kim, HW; Kim, JS; Lee, BS; Lee, JW; Lee, SK; Lee, YI; Park, HW; Whang, J; Yoon, HS; Yu, AR, 2022) |
| "Colitis is generally affected by multiple factors, including the dysbiosis of intestinal microbiota, and may affect organs outside colon through circulation." | ( Cui, SW; Fan, L; Fang, Q; Nie, S; Tan, H; Wu, Q; Yang, J; Zhang, Y, 2022) |
| "Colitis is a major risk factor for the development of colorectal cancer, leading to colitis-associated colorectal cancer (CAC)." | ( Eferl, R; Gushchina, V; Kallay, E; Kupper, N; Manhardt, T; Mesteri, I; Moritsch, S; Müller, C; Piatek, K; Salzmann, M; Schepelmann, M; Vlasaty, A, 2022) |
| "Colitis is a chronic relapsing inflammatory disease of colon." | ( Chen, Q; Feng, W; Liu, M; Wang, D; Wang, T; Wu, J; Wu, Y; Yu, H; Zhang, Y, 2022) |
| "Colitis is an important risk factor for the development of colorectal cancer (CRC)." | ( Chen, X; Hou, Y; Li, CC; Shi, J; Wang, Y; Wu, Q; Xiang, S; Zheng, H; Zhou, Y, 2022) |
| "Colitis is a frequently occurred side effect of immune checkpoint inhibitors (ICIs), which are increasingly used in cancer treatment, whereas antibiotics are widely used to treat colitis, their effectiveness in ICI-associated colitis remains controversial." | ( Ai, C; Jiang, G; Jing, N; Liu, Z; Wang, L; Zhuang, H, 2022) |
| "Ulcerative colitis is an idiopathic disease that is widely incident worldwide." | ( Abdelhamid, AM; Amin, NA; Cavalu, S; El-Ahwany, E; El-Azez, RA; El-Rafi, AA; El-Sandarosy, R; Elagamy, HI; Essam, M; Essam, N; Gaafar, AGA; Girgis, S; Hasaballah, A; Kamal, I; Mahmoud, F; Mansour, M; Mohamed, D; Mohammed, OA; Nasr, M; Rizk, H; Saber, S; Youssef, ME, 2022) |
| "Ulcerative colitis is an inflammatory bowel disease characterized by symptoms such as abdominal pain, diarrhea, bleeding, and weight loss." | ( Kim, SK; Park, SY; Yeom, JE, 2022) |
| "Ulcerative colitis is an inflammatory bowel disease characterized by symptoms such as abdominal pain, diarrhea, bleeding, and weight loss." | ( Kim, SK; Park, SY; Yeom, JE, 2022) |
| "Ulcerative colitis is an inflammatory bowel disease characterized by symptoms such as abdominal pain, diarrhea, bleeding, and weight loss." | ( Kim, SK; Park, SY; Yeom, JE, 2022) |
| "Ulcerative colitis is a multifactorial disease of the gastrointestinal tract which is caused due to chronic inflammation in the colon; it usually starts from the lower end of the colon and may spread to other portions of the large intestine, if left unmanaged." | ( Ahmad, A; Khan, R; Kumar, A; Mishra, RK; Nadeem, A; Raza, SS; Sakla, R; Siddiqui, N; Vyawahare, A, 2023) |
| "Ulcerative colitis is a multifactorial disease of the gastrointestinal tract which is caused due to chronic inflammation in the colon; it usually starts from the lower end of the colon and may spread to other portions of the large intestine, if left unmanaged." | ( Ahmad, A; Khan, R; Kumar, A; Mishra, RK; Nadeem, A; Raza, SS; Sakla, R; Siddiqui, N; Vyawahare, A, 2023) |
| "Colitis is a common and complex intestinal inflammatory disease in which lactate, a metabolite of anaerobic glycolysis, plays a crucial role." | ( Chen, D; Fan, Z; He, J; Huang, Z; Luo, J; Luo, Y; Mao, X; Wang, M; Yan, H; Yu, B; Yu, J; Zheng, P, 2023) |
| "ICI-induced colitis is a frequently reported irAE, whereas enteritis is rare and not well documented." | ( Andersen, JB; Bjerrum, JT; Dahl, EK; Ellebaek, E; Helms, M; Holmstroem, RB; Nielsen, HV; Seidelin, JB; Svane, IM, 2022) |
| "Severe colitis is a common side effect of chemotherapy in cancer patients." | ( Han, X; Li, Z; Liu, M; Qiu, X; Ren, Y; Sriwastva, MK; Teng, LA; Wang, S; Zhang, X; Zhen, L, 2023) |
| "Ulcerative colitis is a chronic inflammatory disease which poorly affects the colon and spreads toward the rectum over time." | ( Ahmad, A; Ali, A; Almashjary, MN; Jori, C; Khan, R; Kumar, A; Mishra, RK; Raza, SS; Tabrez, S; Zughaibi, TA, 2023) |
| "Acute colitis is characterised by an unpredictable onset and causes intestinal flora imbalance together with microbial migration, which leads to complex parenteral diseases." | ( Cao, G; Hao, R; Li, N; Qiao, H; Wang, J; Wei, X; Wu, X, 2023) |
| "Ulcerative colitis is an inflammatory bowel disease (IBD) with relapsing and remitting patterns, and it is caused by varied factors, such as the intestinal inflammation extent and duration." | ( Jeon, SM; Kim, HH; Kim, K; Kim, KY; Kim, YJ; Shin, CS; Song, YH; Yoon, JW, 2023) |
| "Ulcerative colitis is characterized as a chronic immune-mediated inflammatory condition, affecting the intestinal gastroenteric tissue." | ( Bhatt, LK; Parihar, N, 2023) |
| "Ulcerative colitis is a chronic inflammation of the colon." | ( Amini-Khoei, H; AnjomShoa, M; Ghasemi-Dehnoo, M; Lorigooini, Z; Rafieian-Kopaei, M, 2023) |
| "Because colitis is a predisposing factor of CRC and inflammation is a major driver of CRC, we sought to evaluate the therapeutic potential of PA in CRC." | ( Bullard, BM; Cardaci, TD; Fan, D; Hofseth, LJ; Huss, AR; McDonald, SJ; Murphy, EA; VanderVeen, BN, 2023) |
| "Radiation colitis is the leading cause of diarrhea and hematochezia in pelvic radiotherapy patients." | ( Fan, X; Feng, Y; He, RR; Li, Z; Liu, M; Luo, X; Wang, Y, 2023) |
| "Ulcerative colitis is a chronic inflammatory disease with a remitting-relapsing clinical course, it has evolved into a global burden given its high incidence worldwide." | ( Fan, B; He, Z; Liu, Z; Qiao, X; Tan, C; Wu, Y; Xing, Y; Yang, D; Yi, J; Yin, J; Zeng, G; Zeng, Y, 2023) |
| "Ulcerative colitis is a relapsing and remitting disease that may be associated with flares." | ( Dutta, U; Jearth, V; Mahajan, G; Patil, AN; Rana, VS; Saroch, A; Sekar, A; Sharma, V; Singh, AK; Singh, H, 2023) |
| "The development of colitis is closely related to changes in gut microbiota." | ( Chen, C; Hu, J; Ji, H; Li, Y; Nie, Q; Nie, S; Shi, Z; Sun, Y; Zhang, H; Zhang, S; Zhao, M, 2024) |
| "Ulcerative colitis is a chronic inflammatory disease with high mortality and morbidity worldwide." | ( Abu-Raghif, A; Jaafar, FR, 2023) |
| Excerpt | Reference |
|---|
| "Vigorous treatment of the colitis became necessary." | ( Bain, M; Drinnan, AJ; Windell, HC; Ziter, W, 1975) |
| "Vehicle-treated colitis animals had gross ulceration, increased myeloperoxidase activity, and net colonic fluid secretion." | ( Cui, N; Fedorak, RN; Friend, DR, 1994) |
| "Compared to untreated colitis the MPO activity in heparin-treated animals was of borderline significance." | ( Canova, E; Carlotto, C; Carraro, P; Fries, W; Gasparini, G; Longo, G; Martin, A; Mazzon, E; Pagiaro, E; Pomerri, F; Sturniolo, GC, 1998) |
| "Neutralization of IFN-gamma in IL-12-treated mice with colitis inhibited these effects of IL-12." | ( Falk, W; Gross, V; Hans, W; Schölmerich, J, 2000) |
| "Antibiotics both prevent and treat the colitis through correction of this primary bacterial alteration." | ( Doyle, JS; Fedorak, RN; Jewell, LD; Madsen, KL; Rennie, RP; Tavernini, MM, 2000) |
| "To investigate the possibility of local treatment of colitis with the adhesive antioxidant enzymes catalase and superoxide dismutase (SOD)." | ( Bass, P; Blau, S; Kohen, R; Rubinstein, A, 2000) |
| "The latter modality is used for the treatment of colitis and hepatitis." | ( Cohen, P; Eliakim, R; Karmeli, F; Rachmilewitz, D; Zimran, A, 2001) |
| "Honey may have some features in the treatment of colitis, but this issue requires further investigation." | ( Bilsel, Y; Bugra, D; Bulut, T; Cevikbas, U; Turkoglu, U; Yamaner, S, 2002) |
| "Novel therapies for the treatment of colitis are required." | ( Boyle, J; FitzGerald, AJ; Ghosh, S; Marchbank, T; May, FE; Playford, RJ; Pu, M; Westley, BR; Yadollahi-Farsani, M, 2004) |
| "5-ASA alone in treatment of colitis induced by trinitrobenzene sulfonic acid (TNBS) in rats." | ( Ancha, HR; Harty, RF; Kurella, RR; Lightfoot, S; McKimmey, CC, 2008) |
| "AOG may be useful for treatment of colitis and prevention of carcinogenesis in the clinics." | ( Cao, SS; Feng, J; Guo, ZJ; Li, C; Li, Q; Li, YH; Liu, L; Mei, QB; Niu, YB; Sun, Y, 2010) |
| "Thalidomide was used as treatment in colitis and arthritis group, whereas etoricoxib was used in CWG group." | ( Khanduja, KL; Medhi, B; Pandhi, P; Rao, RS, 2010) |
| "CyA-MS might be possible to treat ulcerative colitis effectively by decreasing the total dosage without the elevation of the serum level or the side effects of CyA." | ( Fukata, N; Fukui, T; Koyabu, M; Kusuda, T; Matsushita, M; Miyoshi, H; Nishio, A; Okazaki, K; Tabata, Y; Uchida, K, 2011) |
| "Studies regarding the treatment of CMV colitis-associated diarrhea are scarce, and are typically limited to treating the underlying cause with antiviral medications and with the addition of antimotility agents." | ( Bartels, MC; Mergenhagen, KA, 2011) |
| "Compared with the untreated colitis group, the curcumin-treated group showed significant decreases in the disease activity index, colonic mucosa damage index, histological score, myeloperoxidase activity, and expressions of NF-κB mRNA, IL-27 mRNA, TLR4 protein, NF-κB p65 protein, and IL-27 p28 protein (p < 0." | ( Chen, L; Liao, H; Lv, X; Zeng, Z; Zhan, L, 2013) |
| "Probiotics effectively treat experimental colitis by increasing CD4+CD25+Foxp3+T cell and regulating the balance of Th1 and Th2 cytokines in the colonic mucosa." | ( Ao, MY; Huang, XY; Liu, DY; Liu, HN; Liu, ZY; Pan, QH; Zhao, HM; Zhou, F; Zuo, ZQ, 2013) |
| "The 1% grape juice-treated induced colitis group showed marked clinical improvement when compared with the TNBS-induced colitis group." | ( Gollücke, AP; Marchi, P; Miszputen, SJ; Neto, RA; Noguti, J; Paiotti, AP; Pastrelo, MM; Pazine, VL; Ribeiro, DA; Silva, RM, 2013) |
| "Se-deficient mice subjected to AOM/DSS treatment to model colitis-associated cancer (CAC) had increased tumor number, though not size, as well as increased incidence of high grade dysplasia." | ( Barrett, CW; Bradley, AM; Burk, RF; Chaturvedi, R; Davies, SS; Fingleton, BM; Hill, KE; Lintel, MK; Matafonova, E; Motley, AK; Ning, W; Parang, B; Poindexter, SV; Reddy, VK; Singh, K; Washington, MK; Williams, CS; Wilson, KT, 2013) |
| "acidophilus) for treating colitis using an experimental murine model." | ( Chen, LL; Li, FJ; Lian, GH; Lu, FG; Zou, YY, 2013) |
| "SYD is effective in treating ulcerative colitis." | ( Cai, H; Diao, J; Fan, Q; Lin, X; Shao, M; Sun, X; Yao, X; Yi, Z; Zhao, L, 2014) |
| "At day 3 after the beginning of the treatment, colitis was induced by intrarectal administration of trinitrobenzene sulfonic acid (TNBS)." | ( Beghyn, T; Deprez, B; Desreumaux, P; Dubreuil, L; Dubuquoy, L; Flament, MP; Guerin-Deremaux, L; Karrout, Y; Moussa, E; Neut, C; Piveteau, C; Siepmann, F; Siepmann, J; Wils, D, 2015) |
| "Histological examination of untreated colitis mice showed a massive loss of crypt architecture and goblet cells, infiltration of immune cells and the presence of edema, while all aspects of this pathology were alleviated by oral enoxaparin." | ( Eri, RD; Gueven, N; Lean, QY; Patel, RP; Peterson, GM; Randall-Demllo, S; Sohal, SS; Stewart, N, 2015) |
| "For the celastrol-treated colitis mice, however, levels of the above lipid markers were restored, together with recovered saturated LPC/unsaturated LPC ratios." | ( Chai, Y; Dai, W; Duan, G; Fan, G; Gonzalez, FJ; Gu, X; Lu, F; Qi, Y; Wang, R; Ye, J, 2016) |
| "The standard protocols for treating colitis conditions are not satisfactory; thus, complementary and alternative medicines have been increasingly accepted by IBD sufferers worldwide." | ( Hou, JT; Li, HW; Li, PW; Liu, FB; Mi, H, 2017) |
| "To provide new insights in treatment of colitis and ischemia and reperfusion in rats using stable gastric pentadecapeptide BPC 157." | ( Antunovic, M; Bilic, Z; Drmic, D; Duzel, A; Gojkovic, S; Kasnik, K; Knezevic, M; Kokot, A; Kolovrat, M; Kralj, T; Krezic, I; Lojo, N; Malekinusic, D; Samara, M; Seiwerth, S; Sever, M; Sikiric, P; Siroglavic, M; Vidovic, T; Vlainic, J; Vrdoljak, B; Vukojevic, J, 2017) |
| "For the efficient treatment of colitis, SFC was coupled with acidic amino acids to yield SFC-aspartic acid (SFC-AA) and SFC-glutamic acid, and their colon targetability and therapeutic effects were assessed as an anticolitic agent in a 2,4-dinitrobenezenesulfonic acid-induced rat colitis model." | ( Jeong, S; Ju, S; Jung, Y; Kim, S; Kim, W; Lee, H; Yoo, JW; Yoon, IS, 2019) |
| "The protective effects of HE-chrysin treatment against colitis were mediated by decreasing Th1- and Th17-type cytokine levels." | ( Bak, DH; Byun, EB; Kim, JM; Lim, ST; Moo Han, J; Sik Kim, W; Song, HY, 2019) |
| "The potential of probiotics for treating ulcerative colitis (UC) has attracted increasing attention." | ( Cui, J; Ma, W; Ning, K; Wang, Y; Xiang, H; Xiang, JY; Xie, Q; Zhang, Y, 2020) |
| "For the second phase, roselle-treated DSS-induced colitis mice were sacrificed on day 7, 14, 21, and 28 after induction and compared with mesalazine-treated DSS-induced colitis mice." | ( Bangun, H; Ilyas, S; Lubis, M; Siregar, GA, 2020) |
| "To analyze the effect of calcitriol treatment on acute colitis in an experimental rat model." | ( Bademci, R; Erbaş, O; Erdoğan, MA; Kara, AY; Yiğittürk, G, 2020) |
| "Collectively, BBR has the capacity to treat DSS-induced colitis in rats through the regulation of gut microbiota associated tryptophan metabolite to activate AhR, which can greatly improve the disrupted gut barrier function." | ( Dong, S; Du, W; Jing, W; Liu, J; Lu, H; Luo, H; Luo, X; Wang, S; Wang, Y; Wei, B; Yang, L, 2021) |
| "To apply the metabolite for the treatment of colitis, 3-IPA was coupled with acidic amino acids to yield colon-targeted 3-IPA, 3-IPA-aspartic acid (IPA-AA) and 3-IPA-glutamic acid (IPA-GA)." | ( Ju, S; Jung, Y; Kim, S; Lee, H; Min, DS; Park, S; Yoo, JW; Yoon, IS, 2021) |
| "Here we determined whether Spd treatment reduces colitis and carcinogenesis." | ( Allaman, MM; Asim, M; Barry, DP; Coburn, LA; Delgado, AG; Finley, JL; Gobert, AP; Latour, YL; Luis, PB; McNamara, KM; Piazuelo, MB; Schneider, C; Sierra, JC; Singh, K; Smith, TM; Washington, MK; Wilson, KT; Zhao, S, 2022) |
| "However, the PPS-treated colitis group showed higher gene expression of IL-35 EBI3 subunit by 1." | ( AbdElfattah, AA; Ashour, RH; El-Kady, RA; Elmasry, A; Hazem, NM, 2022) |
| "However, the efficacy and safety of treatment of severe colitis is poorly understood." | ( Abed, OK; Agnholt, JS; Bjerrum, JT; Dahl, EK; Dige, A; Donia, M; Kjeldsen, J; Seidelin, JB; Svane, IM, 2022) |
| "Also, vitexin treatment in colitis mice markedly inhibited the production of pro-inflammation cytokines (such as IL-1β, IL-6, and TNF-α)." | ( Chen, Y; Chen, Z; Hou, S; Huang, S; Liang, F; Liang, J; Liu, C; Xiong, Q; Yuan, J; Zhang, J, 2022) |
| "The medicine may treat chronic colitis through PI3 K-Akt, VEGF, HIF-1, and TNF signaling pathways." | ( Chen, YX; Gong, QF; Wang, C; Wu, XY; Xiang, Q; Xiao, XL; Yang, DY; Yu, H; Zhao, WY; Zhu, YH, 2022) |
| "The medicine may treat chronic colitis through PI3 K-Akt, VEGF, HIF-1, and TNF signaling pathways." | ( Chen, YX; Gong, QF; Wang, C; Wu, XY; Xiang, Q; Xiao, XL; Yang, DY; Yu, H; Zhao, WY; Zhu, YH, 2022) |
| "As potential candidates for treating ulcerative colitis (UC), polysaccharides have been attracting extensive interest in recent years." | ( Chen, C; Chen, S; Cui, SW; Dong, N; Fang, Q; Nie, S; Wang, J; Zhang, Y, 2023) |
| "As the first-line drug to treat ulcerative colitis (UC), long-term use of glucocorticoids (GCs) produces severe toxic and side effects." | ( Deng, SJ; Dong, K; Guan, ZL; Guo, ZY; He, BY; Leng, X; Ma, RR; Wang, DY; Xing, JF; You, CY, 2023) |
| "However, the existing treatments of colitis are associated with poor outcomes, and the current strategies remain deep and long-time remission and the prevention of complications." | ( Jiang, H; Li, R; Liu, P; Luan, H; Xu, Y; Zhang, Y; Zhao, Y, 2023) |
| "(AMP) in treating ulcerative colitis as the example, we checked the effects of AMP on tryptophan metabolites." | ( Feng, WW; Hu, P; Jiang, Z; Liu, J; Yan, X; Zeng, Y, 2023) |
| "HBO effectively treats TNBS-induced colitis by increasing the activity of antioxidant enzymes and modulating cytokine profiles." | ( Achtschin, CG; de Alencar, DT; Dos Santos, FM; Leite, AZA; Nakutis, FS; Nishitokukado, I; Nunes, VS; Ortiz-Agostinho, CL; Sipahi, AM, 2023) |